Efficacy, Safety and Biomarkers of SG001 for Patients with Previously Treated Recurrent or Metastatic Cervical Cancer: an Open-Label, Multicenter, Phase Ib Trial
Cancer communications (London, England)(2024)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined